In-utero tolerance

Current Opinion in Organ Transplantation

Volumn 11, Issue 4, 2006, Pages 353-359

  Peranteau, William H ^a   Flake, Alan W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Allogeneic transplantation; Fetus; In utero transplantation; Tolerance

Indexed keywords

LEUCYLLEUCINE METHYL ESTER; PSORALEN DERIVATIVE;

ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL POPULATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE STRAIN; NONHUMAN; ORGAN TRANSPLANTATION; PERINATAL PERIOD; PRENATAL PERIOD; PRIMATE; RAT STRAIN; REVIEW; SHEEP; SWINE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ULTRAVIOLET A RADIATION; UTERUS; XENOGRAFT;

EID: 33746329280     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000236696.99468.8f     Document Type: Review

References (63)

1. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine cattle twins. Science 1945; 102:400-401.
2. Anderson D, Billingham R, Lampkin G, Medawar PB. The use of skin grafts to distinguish between monozygotic and dizygotic twins in cattle. Heredity 1951; 5:379-397.
3. Billingham RE, Lampkin GH, Medawar PB, Williams HLL. Tolerance to homografts, twin diagnosis, and the freemartin condition in cattle. Heredity 1952; 6:201-212.
4. Simonsen M. The acquired immunity concept in kidney homotransplantations. Ann NY Acad Sci 1955; 58:448-452.
5. Billingham R, Brent L, Medawar PB. Activity acquired tolerance of foreign cells. Nature 1953; 172:603-606.
6. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A 1996; 93:2264-2271.
7. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005; 435:590-597. This paper highlights mechanisms, including those on a genetic level, involved in self-tolerance. Similar mechanisms may presumably occur following in-utero transplantation for tolerance induction.
8. Sprent J. Central tolerance of T cells. Int Rev Immunol 1995; 13:95-105.
9. Carrier E, Lee TH, Busch MP, Cowan MJ. Induction of tolerance in non-defective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood 1995; 86:4681-4690.
10. Kim HB, Shaaban AF, Milner R, et al. In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J Pediatr Surg 1999; 34:726-729; discussion 729-30.
11. Weissman IL. Developmental switches in the immune system. Cell 1994; 76:207-218.
12. Chen JC, Chang ML, Lee H, Muench MO. Haploidentical donor T cells fail to facilitate engraftment but lessen the immune response of host T cells in murine fetal transplantation. Br J Haematol 2004; 126:377-384.
13. + T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation. Fetal Diagn Ther 2005; 20:35-43. This paper evaluates a cell population with the potential to increase the incidence of in-utero tolerance induction. The cell population has been shown in postnatal studies to have an immune suppressive function. Therefore, this paper highlights, among other things, a potential fetal immune barrier to tolerance induction.
14. Mathes DW, Solari MG, Randolph MA, et al. Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow. Transplantation 2005; 80:1300-1308. This paper describes one of the few studies demonstrating, in a large animal model, that in-utero tolerance induction can serve as a platform for postnatal organ transplantation. The technique used for in-utero injection (injection through the intrahepatic portion of the umbilical vein) and the composition of T cells in the donor cell inoculum are different from those of other groups published and may contribute to their excellent results.
15. Mathes DW, Yamada K, Randolph MA, et al. In utero induction of transplantation tolerance. Transplant Proc 2001; 33:98-100.
16. Ashizuka S, Peranteau WH, Hayashi S, Flake AW. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol 2006; 34:359-368. This paper highlights the ability of in-utero tolerance induction to allow for successful nontoxic postnatal allogeneic cellular transplantations. It highlights the correlation between postnatal chimerism levels and tolerance induction following in-utero transplantation.
17. Hayashi S, Peranteau WH, Shaaban AF, Flake AW. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 2002; 100:804-812.
18. Shaaban AF, Kim HB, Pameijer C, et al. Direct antigen presentation by donor cells in prenatal hematopoietic chimeras results in deletion of donor reactive T cell clones without MHC restriction. Transplantation 2000; 69 (Supplement):S241.
19. Peranteau WH, Hayashi S, Hsieh M, et al. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. Blood 2002; 100:2225-2234.
20. Bacchetta R, Vandekerckhove BA, Touraine JL, et al. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells. J Clin Invest 1993; 91:1067-1078.
21. Roncarolo MG, Yssel H, Touraine JL, et al. Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera. J Exp Med 1988; 167:1523-1534.
22. Touraine JL, Roncarolo MG, Raudrant D, et al. Induction of transplantation tolerance in humans using fetal cell transplants. Transplant Proc 2005; 37:65-66. This study is important to the field of in-utero tolerance induction because it demonstrated a correlation between results in animal studies and limited clinical experience. It provided insights into the mechanism of tolerance induction after in-utero transplantation in humans.
23. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-1164.
24. Muench MO. In utero transplantation: baby steps towards an effective therapy. Bone Marrow Transplant 2005; 35:537-547. This is an excellent review of the collective clinical experience of multiple groups with in-utero transplantation and tolerance induction. It highlights the limited success that has thus far been achieved and the need for future research if the full potential of in-utero tolerance induction is to be achieved.
25. Bartolome J, Porta F, Lafranchi A, et al. B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency. Bone Marrow Transplant 2002; 29:625-628.
26. Flake AW, Roncarolo MG, Puck JM, et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996; 335:1806-1810.
27. Gil J, Porta F, Bartolome J, et al. Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells. Transplant Proc 1999; 31:2581.
28. Pirovano S, Notarangelo LD, Malacarne F, et al. Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output. Haematologica 2004; 89:450-461.
29. Touraine JL, Raudrant D, Golfier F, et al. Reappraisal of in utero stem cell transplantation based on long-term results. Fetal Diagn Ther 2004; 19:305-312.
30. Wengler GS, Lanfranchi A, Frusca T, et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 1996; 348:1484-1487.
31. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 1999; 94:2179-2191.
32. Peranteau WH, Hayashi S, Kim HB, et al. In utero hematopoietic cell transplantation: what are the important questions? Fetal Diagn Ther 2004; 19:9-12.
33. Tse DB, Ching E, Yousefzadeh N, et al. Heterogeneity in fetal immunocompetence during the second trimester of gestation Implications for treatment of nonimmune genetic disorders by in utero transplantation. Fetal Diagn Ther 2005; 20:175-181. This study pointed to the potential of the fetal immune system to serve as a barrier to in-utero engraftment and tolerance induction.
34. Donahue J, Gilpin E, Lee TH, et al. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation. Transplantation 2001; 71:359-368.
35. Moustafa ME, Srivastava AS, Nedelcu E, et al. Chimerism and tolerance postin utero transplantation with embryonic stem cells. Transplantation 2004; 78:1274-1282.
36. Sefrioui H, Donahue J, Gilpin EA, et al. Tolerance and immunity following in utero transplantation of allogeneic fetal liver cells: the cytokine shift. Cell Transplant 2003; 12:75-82.
37. - cells. Exp Hematol 2002; 30:617-624.
38. Rizzia M, Gerloni M, Srivastava AS, et al. In utero DNA immunisation. Immunity over tolerance in fetal life. Vaccine 2005; 23:4273-4282. This study highlights that it is possible to immunize the fetus, despite the previous held belief that the immaturity of the developing fetal immune system prevents it from such a process. This study is important to the field of in-utero transplantation and tolerance induction because it forces one to consider the fetal immune system as a potential barrier to engraftment.
39. Shields LE, Gaur L, Delio P, et al. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates. Stem Cells 2004; 22:759-769.
40. Manoussaka MS, Smith RJ, Conlin V, et al. Fetal mouse NK cell clones are deficient in Ly49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro. J Immunol 1998; 160:2197-2206.
41. Toomey JA, Shrestha S, de la Rue SA, et al. MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. Eur J Immunol 1998; 28:47-56.
42. Van Beneden K, De Creus A, Debacker V, et al. Murine fetal natural killer cells are functionally and structurally distinct from adult natural killer cells. J Leukoc Biol 1999; 66:625-633.
43. Van Beneden K, Stevenaert F, De Creus A, et al. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol 2001; 166:4302-4311.
44. Hedrick MH, Rice HE, MacGillivray TE, et al. Hematopoietic chimerism achieved by in utero hematopoietic stem cell injection does not induce donor-specific tolerance for renal allografts in sheep. Transplantation 1994; 58:110-111.
45. Bhattacharyya S, Chawla A, Smith K, et al. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice. J Immunol 2002; 169:6133-6140.
46. Crombleholme TM, Harrison MR, Zanjani ED. In utero transplantation of hematopoietic stem cells in sheep: the role of T cells in engraftment and graft-versus-host disease. J Pediatr Surg 1990; 25:885-892.
47. Rubin JP, Cober SR, Butler PE, et al. Injection of allogeneic bone marrow cells into the portal vein of swine in utero. J Surg Res 2001; 95:188-194.
48. Shields LE, Gaur LK, Gough M, et al. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 2003; 21:304-314.
49. Lee PW, Cina RA, Randolph MA, et al. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs. Exp Hematol 2005; 33:371-379. This study evaluated the role of T cells in the donor innoculum for in-utero transplantation in a large animal model. It is of great interest to those whose goal it is to translate in-utero tolerance induction more successfully into the clinics, as their techniques for donor-cell processing and composition have yielded the most consistent successful results to date.
50. Hayashi S, Hsieh M, Peranteau WH, et al. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes. Exp Hematol 2004; 32:290-299.
51. - dendritic cells in a fetal mouse model. Transplantation 2001; 72:1768-1776.
52. Bhattacharyya S, Cowan MJ. B72-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2005; 11:657-671. The addition of a facilitating cell population to the donor-cell inoculum is one way to potentially overcome barriers to in-utero tolerance induction. This article is of importance to those interested in the study of in-utero tolerance induction as it highlights this possibility and mandates that the reader evaluate other cell populations.
53. Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol 1999; 27:1569-1575.
54. Almeida-Porada G, Porada CD, Tran N, Zanjani ED. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95:3620-3627.
55. Taylor PA, McElmurry RT, Lees CJ, et al. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood 2002; 99:1870-1872.
56. + mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in nonhuman primates. J Med Primatol 2005; 34:201-208. This study is of interest to those studying in-utero tolerance induction because it highlights the inability of the donor cell to compete with the host cell as a barrier to engraftment and forces one to evaluate the benefits of different donor-cell populations.
57. Sasaki K, Nagao Y, Kitano Y, et al. Hematopoietic microchimerism in sheep after in utero transplantation of cultured cynomolgus embryonic stem cells. Transplantation 2005; 79:32-37. This study is of great interest to those studying in-utero tolerance induction because it highlights the potential of the fetal immune system to serve as a barrier to engraftment and provides evidence that it is possible to sensitize, not tolerize, the fetus after in-utero transplantation.
58. Mychaliska GB, Rice HE, Tarantal AF, et al. In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys. J Pediatr Surg 1997; 32:976-981.
59. Kim HB, Shaaban AF, Yang EY, et al. Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res 1998; 77:1-5.
60. Lee PW, Cina RA, Randolph MA, et al. In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in Swine. Transplantation 2005; 79:1084-1090. This study is of great interest because it describes the successful application of in-utero tolerance induction to postnatal organ transplant in a large animal model. It is a study that highlights the great potential of in-utero tolerance induction.
61. Shen Z, Mohiuddin M, DiSesa VJ. Fetal inoculation with donor cells in cardiac xenotransplantation. Ann Thorac Surg 1996; 62:1360-1363.
62. Tanaka SA, Hiramatsu T, Oshitomi T, et al. Induction of donor-specific tolerance to cardiac xenografts in utero. J Heart Lung Transplant 1998; 17:888-891.
63. Donahue J, Gilpin E, Young D, Carrier E. Postnatal cytokines and boosts improve chimerism and hematological parameters in beta-thalassemic mice transplanted in utero. Transplantation 2001; 71:1491-1494.